Status:
UNKNOWN
Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery
Lead Sponsor:
Assiut University
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
The study aims to analyze the role of left ventricular and left atrial functional parameters by speckle tracking echocardiography in predicting outcome after mitral valve replacement and targeting for...
Detailed Description
Without surgical treatment, the 10-year morbidity and mortality for patients with severe mitral regurgitation can be as high as 90%. In contrast, with successful surgical correction of mitral regurgi...
Eligibility Criteria
Inclusion
- Patients with rheumatic severe mitral regurgitation who will have mitral valve replacement in Assiut University Heart Hospital
Exclusion
- Degenerative mitral regurgitation, ischemic mitral regurgitation, severe rheumatic mitral regurgitation with atrial fibrillation or impaired left ventricular ejection fraction, associated mitral stenosis, or significant aortic regurgitation and ischemic heart disease.
Key Trial Info
Start Date :
September 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03870516
Start Date
September 20 2021
End Date
September 1 2023
Last Update
May 26 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.